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To the Editor,
Possibly lethal infections must be recognized immediately
and readily-available characteristic laboratory findings
could speed up essential decision making. Here, we
present two cases of lethal infection with Clostridium
perfringens. This anaerobic, gram-positive, rod shaped
bacterium, which can be found in soil as well as the
intestinal and genitalmicrobiome of healthy individuals [1,
2], is most commonly known for its ability to cause food-
poisoning. While uncommon, infection may lead to lethal
sepsis with complications such as gas gangrene, necrotic
myositis, and most notably, massive intravascular hemo-
lysis. With a mortality rate of 70–100%, timely recognition
of C. perfringens sepsis is of utmost importance [1]. Several
clinical case reports have been published [1, 3–5], but none
have focused on the laboratory’s perspective. Here, we
emphasize on characteristic and readily-available labora-
tory findings that could support the clinician in timely
identification and diagnosis.
Case A, a 61-year-old male, presented with progressive
lower back pain, nausea and vomiting. Physical exami-
nation showed a perceptive but restless man with scleral
icterus, fever, tachycardia, and tachypnea. Computed to-
mography revealed one large (∼4.6 cm) and multiple
smaller gas-containing hepatic lesions. A single dose of
cefuroxime was administered and blood sampling was
performed for routine clinical chemistry, hematology and
microbiology tests. Due to excessive hemolytic plasma,
clinical chemistry results could not be provided. His he-
moglobin (Hb) level was 1.6 mmol/L and the direct anti-
globulin test (DAT) was negative. The patient’s condition
deteriorated rapidly and he was transferred to the ICU. He
died within 5 h of presentation due to multiple organ fail-
ure. Later, blood culture tests came back positive for
C. perfringens. Autopsy also revealed C. perfringens in the
liver lesions.
Case B, a 71-year-old female, presented with acute
abdominal pain, vomiting, and diarrhea. Physical exami-
nation revealed tenderness in the right upper quadrant of
the abdomen, but no clinical signs of cholecystitis. There
were no other complaints or fever and her vital signs were
normal. Laboratory results showed a normal Hb concen-
tration (9.2 mmol/L), increased leukocyte count, normal
C-reactive protein, elevated hepatobiliary enzymes and
bilirubin, and markedly elevated amylase. Suspecting
biliary pancreatitis, she was admitted for treatment. The
next day, medical ultrasound showed signs of cholangitis,
for which she received cefuroxime and tobramycin. 36 h
later, she developed a fever, hematuria, icterus and
tachypnea. Laboratory results showed an Hb concentration
of 2.0 mmol/L, a negative DAT and a high thrombocyte
count of 1060× 109/L. Clinical chemistry results could not be
provided due to excessive hemolysis. She was admitted to
the ICU where she received several units of plasma, throm-
bocytes, and erythrocytes, raising her Hb to 4.8 mmol/L.
Because blood cultures came back positive forC. perfringens
and gram-positive cocci, ceftriaxone was added. During the
night, her Hb dropped to 2.3 mmol/L and the patient un-
expectedly died from circulatory failure. Upon autopsy, 2 L
of blood were found in the abdominal and thoracic cavities
resulting from perforation of the right atrium due to
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necrosis. Additionally, gas lesions were found in the liver,
most likely due to C. perfringens infection.
The pathophysiology of C. perfringens infection results
from release of alpha-toxin (phospholipase C), which binds
to phospholipid membranes [6], hydrolyzing phospho-
lipids into fatty acids, leading to membrane damage and
cell lysis. In vascular smooth muscle and endothelium, the
released free fatty acids induce leukotriene, prostaglandin,
and thromboxane production, causing local vasoconstric-
tion and coagulation to create an anaerobic environment
for bacterial proliferation. Additional anaerobic fermenta-
tion enzymes lead to gas gangrene [7]. Immediate treat-
ment is of utmost importance for a chance of survival [1].
Treatment includes antimicrobial therapy and support of
vital functions, and preferentially also surgical removal of
the focus, if known [1, 4].
The most obvious laboratory finding in both cases was
excessive hemolysis. The plasma had turned dark brown-
red and samples were automatically flagged as immea-
surable due to free hemoglobin interference. On the Roche
Cobas and Siemens Vista platforms, this occurs when the
‘hemolytic index’ is higher than the allowed set value [8].
Hemolytic samples in itself are not rare and may occur in
vitro in up to 1–10% of all samples due to pre-analytical
factors related to blood drawing, specimen handling and
storage, without any underlying disease [9]. However,
extreme hemolysis is unlikely to be caused by pre-
analytical factors. Hence, the occurrence of intravascular
hemolysis of this magnitude should be reported to the
clinician immediately.
Besides interference on clinical chemistry analyzers,
free Hb also leads to erroneous results in hematology ana-
lyzers. Both Siemens Advia 2120i (Siemens Healthineers,
Erlangen, Germany; Case A) and Sysmex XN1000 analyzers
(SysmexCorporation, Kobe, Japan;CaseB)measureHbafter
lysis of erythrocytes in vitro. By default, any free Hb already
present due to in vivo hemolysis is indistinguishable from
intracellular Hb. Recently, both Siemens and Sysmex
introduced calculated intracellular Hb concentrations with
proprietary algorithms via erythrocyte forward scatter
characteristics [10]. In case A, the conventionally measured
total Hb concentration was substantially different from the
calculated intracellular Hb: 5.6 mmol/L vs. 1.6 mmol/L,
respectively. After visually inspecting the hematocrit in a
centrifuged tube, the result of 1.6 mmol/L was reported to
the clinician. Similarly, in case B the Hb concentration as
measured conventionally was 6.0 mmol/L, while the
calculated intracellular Hb was 2.0 mmol/L after in vivo
hemolysis had started. This low Hb was confirmed by
replacing the hemolytic plasma with saline and subse-
quently measuring the total Hb. Hence, these calculated
intracellular Hb results proved to be indispensable in
assessing the severity of both patients’ conditions.
The free Hb originated from erythrocytes affected by the
alpha-toxin, which causes profound morphologic changes
and hemolysis [6]. Initially, erythrocytes start leaking, then
lose their biconcave shape and ultimately fall apart. Both the
leakage of cytoplasm and membrane rearrangement pro-
gressively lead to smaller cell diameters and a spherical cell
shape [1, 4, 5]. In a blood smear, these changes can be
spherocytes and marked anisocytosis can be recognized.
Ultimately, small, Hb-deprived cells, may be seen as ‘ghost
cells’ in a peripheral blood smear, although they are easily
missed if not specifically paid attention to (Figure 2). Fortu-
nately, these morphological changes can be recognized on
hematology analyzers as well. Unusual microcytic pop-
ulations where found in the RBC histograms of both patients
Figure 1: Sysmex XN1000 hematology analyzer results during
Clostridium perfringens sepsis.
(A) Histograms illustrating a microcytic population of erythrocytes
(ghost cells) in case B. Similar histogramswere seen in case A on the
Siemens Advia 2120i. (B) The ghost cells (encircled) were
misidentified as platelets due to their reduced size in the optical
platelet count. (C) The spherocytes (encircled) showed a marked
interaction with the polymethine dye used in the reticulocyte
channel, leading to misidentification as mature reticulocytes. One
would normally expect to find predominantly young reticulocytes
(orange population on the far right) in severe hemolysis.
Abbreviations: PLT, platelets; GC, ghost cells; RBC, red blood cells.
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(Figure 1A). These small erythrocytes, i.e., ghost cells, were
counted as thrombocytes in patient B, leading to a falsely
highplatelet count of 1060× 109/L.Additionally, spherocytes
and ghost cells showed up in characteristic locations in the
scattergrams for optical platelet and reticulocyte counts
(Figure 1B and C). These cytometry results could help auto-
mated identification of ghost cells.
Summarizing, massive hemolysis (e.g. dark-red
plasma, interference on chemistry platforms), ghost cells
in peripheral blood smears and distinct microcytic eryth-
rocyte populations (resulting in falsely elevated platelet
counts) may occur as indirect indicators of a C. Perfringens
sepsis. Timely recognition of these telltale signs and con-
tact with the physician may aid early diagnosis and treat-
ment of C. perfringens sepsis long before blood culture
results are available.
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Figure 2: Ghost cells as a result of the
Clostridium perfringens alpha toxin in case
B (arrows).
The picture on the right was edited to
increase visibility of these perforated,
microcytic erythrocytes.
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